Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 14,969 | 802 | 44,703 | 268 |
| Gross Profit | N/A | 14,969 | 802 | 44,703 | 268 |
| Operating Expenses | 70,555 | 82,939 | 84,716 | 48,744 | 45,489 |
| Operating Income | -70,555 | -67,970 | -83,914 | -4,041 | -45,221 |
| Interest Expense | 51 | 53 | 28 | 19 | 2,668 |
| Other Income | 3,973 | 6,796 | 7,420 | 4,910 | -3,251 |
| Pre-tax Income | -66,633 | -61,227 | -76,522 | 850 | -51,140 |
| Income Tax | -175 | -44 | -3,075 | -4,471 | -28 |
| Net Income Continuous | -66,458 | -61,183 | -73,447 | 5,321 | -51,112 |
| Minority Interests | -30 | -109 | -100 | -21 | -247 |
| Net Income | $-66,428 | $-61,074 | $-73,347 | $5,342 | $-50,865 |
| EPS Basic Total Ops | -1.64 | -1.55 | -1.91 | 0.14 | -1.96 |
| EPS Basic Continuous Ops | -1.64 | -1.55 | -1.91 | 0.14 | -1.97 |
| EPS Diluted Total Ops | -1.64 | -1.55 | -1.91 | 0.14 | -1.96 |
| EPS Diluted Continuous Ops | -1.64 | -1.55 | -1.91 | 0.14 | -1.97 |
| EPS Diluted Before Non-Recurring Items | -1.52 | -1.55 | -1.91 | 0.14 | -1.67 |
| EBITDA(a) | $-64,710 | $-62,170 | $-78,485 | $282 | $-44,619 |